Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2005-07-19
2005-07-19
Navarro, Mark (Department: 1645)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C424S263100, C424S200100, C424S190100, C536S023100, C536S023700, C514S04400A
Reexamination Certificate
active
06919187
ABSTRACT:
Compounds and methods for the diagnosis and treatment of Chlamydial infection are disclosed. The compounds provided include polypeptides that contain at least one antigenic portion of aChlamydiaantigen and DNA sequences encoding such polypeptides. Pharmaceutical compositions and vaccines comprising such polypeptides or DNA sequences are also provided, together with antibodies directed against such polypeptides. Diagnostic kits containing such polypeptides or DNA sequences and a suitable detection reagent may be used for the detection of Chlamydial infection in patients and in biological samples.
REFERENCES:
patent: 4118469 (1978-10-01), Caldwell et al.
patent: 4497899 (1985-02-01), Armstrong et al.
patent: 5166053 (1992-11-01), Huguenel et al.
patent: 5318892 (1994-06-01), Watanabe et al.
patent: 5725863 (1998-03-01), Daniels et al.
patent: 5869608 (1999-02-01), Caldwell et al.
patent: 6166177 (2000-12-01), Probst et al.
patent: 6432916 (2002-08-01), Probst et al.
patent: 6448234 (2002-09-01), Fling
patent: 6565856 (2003-05-01), Skeiky et al.
patent: 348725 (1990-01-01), None
patent: 784059 (1997-07-01), None
patent: WO 94/06827 (1994-03-01), None
patent: WO 97/06263 (1997-02-01), None
patent: WO 98/02546 (1998-01-01), None
patent: WO 98/10789 (1998-03-01), None
patent: WO 99/17741 (1999-04-01), None
patent: WO 99/27105 (1999-06-01), None
patent: WO 99/28475 (1999-06-01), None
patent: WO 99/51748 (1999-10-01), None
patent: WO 00/34483 (2000-06-01), None
patent: WO 01/40474 (2001-06-01), None
Stephenes et al 1998 (Accession No. H71468 and AE001353).
Unanue. ER 1999 (see attached review article, American Journal of Pathology, 154; 651-664).
Burgess et al., The Journal of Cell Biology, 111:2129-2138, 1990.
Jobling et al. (Mol. Microbiol., 1991, 5(7):1755-67.
Allen and Stephens, “An intermolecular mechanism of T cell help for the production of antibodies to the bacterial pathogen,Chlamydia trachomatis,” European Journal of Immunology 23: 1169-1172, 1993.
Baehr et al., “Mapping antigenic domains expressed bychlamydia trachomatismajor outer membrane protein genes,”Proc Natl Acad Sci 85(1):4000-4004, Jun. 1, 1988.
Brunham et al., “Chlamydia trachomatisantigens: role in immunity and pathogenesis,”Infectious Agents and Disease 3(5):218-233, Oct. 1994.
Chakrabarti et al., “Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques,”Molecular and Cellular Biology 5(12):3403-3409, Dec. 1985.
Conlan, J.W. et al., “Isolation of recombinant fragments of the major outer-membrane protein ofChlamydia trachomatis: their potential as subunit vaccines,”Journal of General Microbiology 136: 2013-2020, 1990.
Earl et al., “Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins and truncations and deletions expressed by recombinant vaccinia viruses,”Journal of Virology 65(1):31-41, Jan. 1991.
GenBank Accession No. AE001273, “Genome sequence of an obligate intracellular pathogen of humans:Chlamydia trachomatis,” Jun. 2, 2004.
Genbank Database, Accession No. AE001316, Jun. 1, 2004.
Genbank Database, Accession No. AE001320, Jun. 1, 2004.
GenBank Database, Accession No. AE001323, “Genome sequence of an obligate intracellular pathogen of humans:Chlamydia trachomatis,” Jun. 1, 2004.
GenBank Database, Accession No. AE001324, “Genome sequence of an obligate intracellular pathogen of humans:Chlamydia trachomatis,” Jun. 1, 2004.
Genbank Database, Accession No. AE001326, Jun. 1, 2004.
GenBank Database, Accession No. AE001335, “Genome sequence of an obligate intracellular pathogen of humans:Chlamydia trachomatis,” Jun. 1, 2004.
Genbank Database, Accession No. AE001361, Jun. 1, 2004.
GenBank Database, Accession No. E71500, “Genome sequence of an obligate intracellular pathogen of humans:Chlamydia trachomatis,” Nov. 3, 2000.
GenBank Database, Accession No. H71501, “Genome sequence of an obligate intracellular pathogen of humans:Chlamydia trachomatis,” Jul. 28, 2000.
GenBank Database, Accession No. H71510, “Genome sequence of an obligate intracellular pathogen of humans:Chlamydia trachomatis,” Oct. 8, 1999.
GenBank Database, Accession No. AAC68408, Jun. 1, 2004.
GenBank Database, Accession No. AAF39070, Mar. 26, 2003.
GenBank Database, Accession No. AE001333, Jun. 1, 2004.
GenBank Database, Accession No. AE002286, Mar. 26, 2003.
GenBank Database, Accession No. AE002343, Mar. 26, 2003.
EMBL Database, Accession No. O84466, Jun. 1, 2003.
GenBank Database, Accession No. NC_000117, Sep. 14, 2004.
Grimwood, J. et al., “Expression ofChlamydia pneumoniaePolymorphic Membrane Protein Family Genes,”Infection and Immunity 69(4):2383-2389, Apr. 2001.
Gu et al., “Chlamydia trachomatisRNA polymerase α subunit: sequence and structural analysis,”J. Bacteriology 177:2594-2601, May 1995.
Hayes, L.J. et al., “Chlamydia trachomatismajor outer membrane protein epitopes expressed as fusions with LamB in an attenuated aroA strain ofSalmonella typhimurium; their application as potential immunogens,”Journal of General Microbiology 137: 1557-1564, 1991.
Hayes, L.J. et al., “The major outer-membrane proteins ofChlamydia trachomatisserovars A and B: intra-serovar amino acid changes do not alter specificities of serovar- and C subspecies-reactive antibody-binding domains,”Journal of General Microbiology 136: 1559-1566, 1990.
Janeway et al. (eds.),Immunobiology: The Immune System in Health and Disease,Garland Pub., New York, NY, 1997, pp. 7:6-7:10.
Jensen et al., “Infection of human and simian tissue cultures with rous sarcoma virus,”Proc. Natl. Acad. Sci. USA 52:53-59, Jul. 1964.
Kalman, S. et al., “Comparative genomes ofChlamydia pneumoniaeandC. trachomatis,” Nature Genetics 21:385-389, Apr. 1999.
Kim, S.-K. et al., “Induction of HLA Class I-Restricted CD8+CTLs Specific for the Major Outer Membrane Protein ofChlamydia trachomatisin Human Genital Tract Infections,”The Journal of Immunology 162: 6855-6866, 1999.
Knudsen, K. et al., “Identification of Two Novel Genes Encoding 97- to 99- Kilodalton Outer Membrane Proteins ofChlamydia pneumoniae,” Infection and Immunity 67(1): 375-383, Jan. 1999.
Kuon, W. et al., “Recognition of Chlamydial Antigen By HLA-B27-Restricted Cytotoxic T Cells in HLA-B*2705 Transgenic CBA(H-2κ) Mice,”Arthritis&Rheumatism 40(5): 945-954, May 1997.
Lalvani et al., “Rapid effector function in CD8+memory T cells,”J. Exp. Med. 186(6):859-865, Sep. 15, 1997.
Lazar, E. et al., “Transforming Growth Factor α: Mutation of Aspartic Acid 47 and Leucine 48 Results in Different Biological Activities,”Molecular and Cellular Biology 8(3): 1247-1252, Mar. 1988.
Levinson and Jawetz,Medical Microbiology&Immunology,3d ed., Appleton & Lange, 1994, pp. 292-293.
Lu and Zhong, “Interleukin-12 Production IS Required for Chlamydial Antigen-Pulsed Dendritic Cells To Induce Protection against LiveChlamydia trachomatisInfection,”Infection and Immunity 67(4): 1763-1769, Apr. 1999.
Maclean, J.W. et al., “Characterization ofChlamydia trachomatisantigens with monoclonal and polyclonal antibodies,”Can. J. Microbiol. 34: 141-147, 1988.
Murdin, A.D. et al., “A Poliovirus Hybrid Expressing a Neutralization Epitope from the Major Outer Membrane Protein ofChlamydia trachomatisIs Highly Immunogenic,”Infection and Immunity 61(10): 4406-4414, Oct. 1993.
Mygind, P.H. et al., “Membrane proteins PmpG and PmpH are major constituents ofChlamydia trachomatisL2 outer membrane complex,”FEMS Microbiol. Lett. 186(2): 163-169, May 15, 2000.
Pal, S. et al., “Immunization with an Acellular Vaccine Consisting of the Outer Membrane Complex ofChlamydia trachomatisInduces Protection against a Genital Challenge,”Infec
Bhatia Ajay
Guderian Jeff
Maisonneuve Jean-Francois L.
Skeiky Yasir A. W.
Baskar Padma
Corixa Corporation
Navarro Mark
Seed IP Law Group PLLC
LandOfFree
Compounds and methods for treatment and diagnosis of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and methods for treatment and diagnosis of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for treatment and diagnosis of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3401640